Irvington, NY, United States of America

Michael Lyons

This inventor holds 1 USPTO granted patent. Top assignee: The Rockefeller University. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Lyons. Retrieved from https://idiyas.com/inventor/michael-lyons-jg4661q9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Lyons - Innovator in Retroviral Treatment

Introduction

Michael Lyons is an accomplished inventor based in Irvington, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of retroviruses. His innovative approach has garnered attention in the scientific community.

Latest Patents

Michael Lyons holds a patent for the "Use of colchicine for the control of retroviruses." This invention relates to treating retroviruses of the leutivirous group with colchicine. His work in this area is crucial for advancing therapeutic options for viral infections.

Career Highlights

Michael is affiliated with The Rockefeller University, where he conducts research and develops innovative solutions in virology. His dedication to scientific inquiry has led to important advancements in understanding and treating viral diseases.

Collaborations

Michael has collaborated with notable colleagues, including William W Hall and Stanley E Read. These partnerships have enriched his research and contributed to the success of his projects.

Conclusion

Michael Lyons is a pioneering inventor whose work in retroviral treatment exemplifies the impact of innovation in medicine. His contributions continue to influence the field and offer hope for improved therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…